Side-by-side comparison of AI visibility scores, market position, and capabilities
St. Petersburg FL diversified financial services (NYSE: RJF) ~$1.4T client assets; #1 J.D. Power 2025 investor satisfaction, advisor-centric culture recruiting from wirehouse firms, investment banking competing with Morgan Stanley.
Raymond James Financial, Inc. is a St. Petersburg, Florida-based diversified financial services company — publicly traded on the New York Stock Exchange (NYSE: RJF) as an S&P 500 Financials component — providing wealth management, investment banking, asset management, and banking services through approximately 8,700 financial advisors and 15,000+ employees across the United States, Canada, Europe, and the UK. Raymond James manages approximately $1.4 trillion in client assets for individuals, families, institutions, municipalities, and corporations through four primary segments: Private Client Group (financial advisor-managed wealth management), Capital Markets (investment banking, equity research, fixed income trading), Asset Management (mutual funds, separately managed accounts), and Raymond James Bank. In the J.D. Power 2025 U.S. Investor Satisfaction Study, Raymond James achieved the highest ranking for investor satisfaction among those working with a dedicated financial advisor — ranked first in trust, people, and product offerings, and recognized as the most trusted company among advised investors — a distinction that validates Raymond James's advisor-centric culture that has made it a leading destination for financial advisors leaving wirehouse firms. CEO Paul Reilly, who has led Raymond James since 2010, has positioned the company as the advisor-friendly alternative to Wall Street wirehouse firms (Merrill Lynch/BofA, Morgan Stanley, UBS) through independence-preserving payout structures, back-office support, and a partnership culture.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.